GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 385 filers reported holding GLOBUS MED INC in Q3 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $37,988 | -99.9% | 511,496 | +0.7% | 0.08% | +24.6% |
| Q3 2022 | $30,267,000 | +5.0% | 508,089 | -1.1% | 0.06% | +15.1% |
| Q2 2022 | $28,829,000 | -24.4% | 513,536 | -0.7% | 0.05% | +3.9% |
| Q1 2022 | $38,153,000 | +5.9% | 517,113 | +3.6% | 0.05% | +15.9% |
| Q4 2021 | $36,036,000 | -6.7% | 499,113 | -1.0% | 0.04% | -6.4% |
| Q3 2021 | $38,630,000 | +1.7% | 504,174 | +2.9% | 0.05% | +2.2% |
| Q2 2021 | $38,000,000 | +30.9% | 490,138 | +4.1% | 0.05% | +21.1% |
| Q1 2021 | $29,038,000 | -5.3% | 470,853 | +0.2% | 0.04% | -7.3% |
| Q4 2020 | $30,647,000 | +75.3% | 469,905 | +33.1% | 0.04% | +64.0% |
| Q3 2020 | $17,486,000 | +2.7% | 353,093 | -1.0% | 0.02% | -7.4% |
| Q2 2020 | $17,023,000 | +21.6% | 356,805 | +8.4% | 0.03% | -6.9% |
| Q1 2020 | $13,997,000 | -10.1% | 329,095 | +24.4% | 0.03% | +11.5% |
| Q4 2019 | $15,574,000 | +7.1% | 264,498 | -7.0% | 0.03% | -7.1% |
| Q3 2019 | $14,546,000 | +74.5% | 284,542 | +44.4% | 0.03% | +75.0% |
| Q2 2019 | $8,338,000 | -19.2% | 197,097 | -5.7% | 0.02% | -20.0% |
| Q1 2019 | $10,325,000 | +39.6% | 208,956 | +22.3% | 0.02% | +17.6% |
| Q4 2018 | $7,397,000 | +73870.0% | 170,906 | +93804.4% | 0.02% | – |
| Q3 2018 | $10,000 | +11.1% | 182 | 0.0% | 0.00% | – |
| Q2 2018 | $9,000 | -10.0% | 182 | -11.7% | 0.00% | – |
| Q1 2018 | $10,000 | +11.1% | 206 | -9.6% | 0.00% | – |
| Q4 2017 | $9,000 | -64.0% | 228 | -72.5% | 0.00% | – |
| Q3 2017 | $25,000 | -37.5% | 830 | -30.8% | 0.00% | – |
| Q2 2017 | $40,000 | +21.2% | 1,199 | +7.1% | 0.00% | – |
| Q1 2017 | $33,000 | +450.0% | 1,120 | +330.8% | 0.00% | – |
| Q4 2016 | $6,000 | 0.0% | 260 | 0.0% | 0.00% | – |
| Q3 2016 | $6,000 | -100.0% | 260 | -100.0% | 0.00% | -100.0% |
| Q2 2016 | $16,124,000 | -2.0% | 676,642 | -2.4% | 0.04% | -6.4% |
| Q1 2016 | $16,460,000 | -30.1% | 693,032 | -29.6% | 0.05% | -29.9% |
| Q2 2014 | $23,553,000 | -13.4% | 984,669 | -3.8% | 0.07% | -13.0% |
| Q1 2014 | $27,210,000 | +49.5% | 1,023,294 | +13.4% | 0.08% | +40.0% |
| Q4 2013 | $18,204,000 | +151600.0% | 902,045 | +135342.2% | 0.06% | – |
| Q3 2013 | $12,000 | – | 666 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |